Altria (NYSE:MO | MO Price Prediction) has staged one of the most surprising rebounds in the consumer defensive sector. After bottoming near $58.19 in November 2025, the stock has ripped back to $72.65, posting a 28.09% year-to-date gain. After a strong Q1 2026 print and reaffirmed guidance, the question is whether the run has more room.
Our 24/7 Wall St. price target for Altria is $73.05, implying just 0.55% upside over the next 12 months. The model assigns a hold rating with a 90% confidence level. In plain language: we believe MO is trading right at fair value after its rally.
24/7 Wall St. Price Target Summary
| Metric | Value |
|---|---|
| Current Price | $72.65 |
| 24/7 Wall St. Price Target | $73.05 |
| Upside | 0.55% |
| Recommendation | HOLD |
| Confidence Level | 90% |
A Q1 Beat That Reignited the Rally
Altria reported Q1 2026 recently, delivering adjusted diluted EPS of $1.32 versus the $1.24 consensus, a 5.92% beat and the fourth consecutive quarter topping estimates. Revenue of $5.43 billion grew 20.1% YoY, helped by 610 million contract-manufactured export sticks. Smokeable adjusted OCI rose 6.3% to $2.68 billion at 65.1% margins.
Shares jumped 6.52% on the earnings report and are up 10.09% over the past month, putting MO within striking distance of its $73.85 52-week high. One year ago, the stock traded at $55.25, a 31.48% total move excluding the roughly 6% dividend yield.
Why Bulls See a Breakout Above $80
The bull case rests on premium pricing power and the smoke-free pivot. Marlboro held a 59.5% share of the premium segment, on! shipment volume rose 17.6%, and U.S. nicotine pouches now command 58.1% of oral tobacco.
Helix is taking on! PLUS nationwide, and the Horizon JV opens U.S. heated tobacco. CEO Billy Gifford said Altria “delivered a strong start to the year, growing adjusted diluted EPS by 7.3% in the first quarter.” If the upper end of $5.72 guidance hits and the multiple expands to 14x, the bull scenario points to $76.68.
The Risks Worth Watching
Domestic cigarette industry volume fell roughly 5% in Q1, Marlboro retail share slipped 1.4 points to 39.7%, and on! lost 4.2 points of category share to 13.4% amid Zyn competition. Negative shareholders’ equity sits at ($3.21 billion), and NJOY ACE remains blocked by an ITC order.
Wall Street’s average analyst target is $65.58, well below the current quote, with 7 Hold ratings versus 5 Buys. Counterfactually, smokeable margins still expanded to 65.1%, suggesting pricing more than compensates for volume erosion. Our bear scenario lands at $64.17.
Hold for Now, Collect the 6% Yield
The 24/7 Wall St. price target of $73.05 implies near-flat capital appreciation, but the 6.14% dividend yield, backed by the 60th consecutive raise, makes this a hold with 90% confidence.
The setup looks more constructive if Marlboro share stabilizes and on! reverses its category losses against Zyn. The thesis weakens if discount cigarette share keeps climbing past 33.3%, signaling that trade-down has become structural.
Altria Price Prediction 2026-2030
| Year | 24/7 Wall St. Price Target |
|---|---|
| 2026 | $73.05 |
| 2027 | $76.50 |
| 2028 | $79.80 |
| 2029 | $82.40 |
| 2030 | $83.97 |
These projections assume Altria sustains low-single-digit EPS growth, retains its premium pricing umbrella, and continues funding the dividend. Significant upside could come from heated tobacco scaling through the Horizon JV, while a faster volume cliff or regulatory crackdown on nicotine pouches would push outcomes toward our base case $83.97 2031 figure.
Top Gaining Stocks
Top Losing Stocks